Levocetirizine Dihcl Sandoz

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Dihcl Sandoz, is an antihistamine presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and children when appropriate. GNH USA supplies Levocetirizine Dihcl Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine Dihcl Sandoz is an antihistamine that targets H1‑mediated allergic pathways. It is used for: - Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery discharge. - Chronic idiopathic urticaria: alleviates hives and associated itching. - Seasonal allergic rhinitis (hay fever): controls typical seasonal allergy symptoms.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild to moderate sleepiness, especially after the first dose. - Dry mouth: reduced salivation causing throat discomfort. - Headache: transient tension‑type headache. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare systemic allergic reaction with respiratory or circulatory compromise.

Before initiating therapy, consider the following precautions: - Renal function assessment: dose adjustment may be needed in severe renal impairment. - Elderly patients: monitor for increased sedation or dizziness. - Alcohol consumption: avoid or limit as it may enhance drowsiness. - Concomitant CNS depressants: use caution when combined with sedatives or hypnotics. - Pediatric use: not recommended for children under six years of age unless specifically prescribed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levocetirizine may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma levels. - Alcohol: can potentiate sedation and impair alertness. - Central nervous system depressants (e.g., benzodiazepines): risk of additive drowsiness.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may modestly raise levocetirizine exposure. - Macrolide antibiotics (e.g., erythromycin): potential for increased sedation. - Theophylline: levocetirizine may slightly raise theophylline concentrations.